ArticleThe Lancet. Oncology2013
New options for second-line therapy of advanced renal cancer.
Axel BexPubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleThe Lancet. Oncology2013
Axel BexPubMed ↗Publisher ↗
No numbers read from the abstract.